Dear Colleagues,

I post this for Dr. Yi Shi at the University of Pittsburgh.

*Description:* a postdoctoral position is available in the Shi laboratory
of antibody biotechnology and proteomics at the Department of Cell Biology,
University of Pittsburgh School of Medicine (UPMC). The laboratory is at
the forefront of developing transformative new technologies that integrate
proteomics, computational biology, and structural approaches for
large-scale antibody (especially camelid VHH antibody/ nanobody) discovery
and characterization. The lab is also interested in applying these
techniques to develop novel nanobody-based therapies for some of the most
devastating diseases including COVID-19, cancer, and neurodegeneration. The
lab is currently funded by several grants including the NIH, MJFF, and
Alzheimer Foundation. More information about our research could be found
here at For the successful incumbent, the initial
appointment is 12 months with the possibility of renewal. Compensation will
follow standard NIH Post-Doc salary rates and is based on experience. We
strongly support the career development of our colleagues and trainees. A
listing of Pitt employee benefits is available at

Highly motivated individuals with a background in biochemistry,
bioengineering, biophysics or structural biology (especially membrane
protein structural biology) are welcome to apply. Successful candidates
should have excellent communication skills and the desire to lead research
projects. Interested candidates may submit their CV including names and
contact information for two-three references, a short description of their
research experience, and research goals to Yi Shi at ( For
more information about our research visit:

*Pittsburgh:* As the second-largest city in Pennsylvania, Pittsburgh is
best known as “the city of Bridges”. In 2015, Pittsburgh was listed among
the “eleven most livable cities in the world” and has been considered as
one of the most livable cities in the United States.

*The University of Pittsburgh is an Equal Opportunity Employer**.*

Cheng Zhang